Asahi Kasei Corporation (AHKSF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 10.92 means the share price is 10.92 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $13.9B is the value of all shares combined. Beta 0.50: the stock has moved about 50% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerAsahi Kasei Corporation (AHKSF) trades at $10.35 with MoonshotScore 46/100 (Grade C). Asahi Kasei Corporation is a diversified Japanese chemical company operating across materials, homes, and healthcare segments. Market cap: $13.9B, Sector: Basic materials.
Price as of Sep 10, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for AHKSF: AHKSF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AHKSF against Basic Materials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
These figures come from statements filed 12 months ago — the most recent this company has published.
AHKSF: 2/3 scored disciplines lean bullish. Dominant signal: Ray Dalio bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Asahi Kasei Corporation (AHKSF) Materials & Commodity Exposure
Asahi Kasei Corporation, a Japanese multinational, operates in the materials, homes, and healthcare sectors, providing a diverse range of chemical products, construction materials, and medical devices. With a global presence and a focus on innovation, the company serves various industries, leveraging its integrated business model.
What Is the Investment Thesis for AHKSF?
Asahi Kasei Corporation presents an investment opportunity driven by its diversified business model and global presence. With a P/E ratio of 10.92 and a dividend yield of 2.51%, the company offers a blend of value and income. However, potential risks include fluctuations in raw material prices and economic downturns affecting the construction and automotive industries. The company's beta of 0.50 suggests lower volatility compared to the market, making it a potentially stable investment. The company’s profit margin stands at 5.2% and gross margin at 32.5%.
Based on FMP financials and quantitative analysis
AHKSF Key Highlights
Market capitalization of $13.9B reflects the company's significant presence in the global chemical industry.
- P/E ratio of 10.92 indicates a potentially undervalued stock compared to its earnings.
- Dividend yield of 2.51% provides a steady income stream for investors.
- Gross margin of 32.5% demonstrates the company's ability to maintain profitability in a competitive market.
- Beta of 0.50 suggests lower volatility compared to the overall market, indicating a potentially stable investment.
Who Are AHKSF's Competitors?
AHKSF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BNTGF Brenntag SE | $69.00 | 0.00% | $9.96B | 449-signal |
| BZZUF Buzzi Unicem S.p.A. | $48.00 | 0.00% | $8.47B | 469-signal |
| GNENY Ganfeng Lithium Group Co., Ltd. | $4.63 | +2.21% | $7.46B | — |
| HGMCF Harmony Gold Mining Company Limited | $20.85 | 0.00% | $13.0B | — |
| DOW Dow Inc. | $29.64 | +0.82% | $21.4B | 465-pillar |
| CE Celanese Corporation | $45.72 | +2.86% | $5.01B | 425-pillar |
| MEOH Methanex Corporation | $62.72 | +0.72% | $4.85B | 725-pillar |
| BFFAF BASF Se | $62.00 | 0.00% | $53.5B | 429-signal |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are AHKSF's Key Strengths?
Diversified business model
- Global presence
- Strong research and development capabilities
- Integrated business model
What Are AHKSF's Weaknesses?
Exposure to cyclical industries
- Dependence on raw material prices
- Competition from larger chemical companies
- Geographic concentration in Japan
What Could Drive AHKSF Stock Higher?
Expansion of healthcare segment through new product development and acquisitions.
- Increasing demand for high-performance materials in automotive and electronics industries.
- Geographic expansion in emerging markets, particularly in Asia.
- Potential partnerships with other companies to develop and commercialize new technologies.
- Launch of new sustainable and environmentally friendly products in response to increasing consumer demand.
What Are the Key Risks for AHKSF?
Economic downturns affecting demand for chemical products and construction materials.
- Fluctuations in raw material prices impacting profitability.
- Increasing environmental regulations increasing compliance costs.
- Technological disruptions rendering existing products obsolete.
- Competition from larger chemical companies with greater resources.
What Are the Growth Opportunities for AHKSF?
- Expansion in the Healthcare Sector: Asahi Kasei's Health Care segment offers significant growth potential, driven by an aging global population and increasing demand for advanced medical devices and pharmaceuticals. The company's focus on dialyzers, therapeutic apheresis, and biotherapeutics positions it to capitalize on this trend. The global medical device market is projected to reach $600 billion by 2028, providing a substantial opportunity for Asahi Kasei to expand its market share.
- Increased Demand for High-Performance Materials: Asahi Kasei's Material segment benefits from the growing demand for high-performance materials in various industries, including automotive, electronics, and construction. The company's expertise in polymers, additives, and membranes allows it to develop innovative solutions for these markets. The global market for advanced materials is expected to reach $100 billion by 2027, driven by increasing demand for lightweight, durable, and sustainable materials.
- Geographic Expansion in Emerging Markets: Asahi Kasei has the opportunity to expand its presence in emerging markets, particularly in Asia and South America, where demand for chemical products and construction materials is growing rapidly. By establishing local manufacturing facilities and distribution networks, the company can reduce transportation costs and improve its responsiveness to customer needs. The emerging markets chemicals market is projected to grow at a rate of 6% per year over the next five years.
- Development of Sustainable and Environmentally Friendly Products: Asahi Kasei can capitalize on the growing demand for sustainable and environmentally friendly products by developing and marketing products that reduce waste, conserve resources, and minimize environmental impact. The company's focus on cellulose nanobead, ecorise, and bemliese products aligns with this trend.
- Strategic Acquisitions and Partnerships: Asahi Kasei can accelerate its growth by pursuing strategic acquisitions and partnerships that complement its existing businesses and expand its product portfolio. By acquiring companies with complementary technologies and market access, the company can enhance its competitive position and enter new markets. The company can also partner with other companies to develop and commercialize new products and technologies.
What Are AHKSF's Competitive Advantages?
- Diversified business model reduces reliance on any single market or product.
- Global presence provides access to a wide range of markets and customers.
- Strong research and development capabilities drive innovation and product differentiation.
- Integrated business model creates synergies across its segments.
What Does AHKSF Do?
Founded in 1922, Asahi Kasei Corporation has evolved from a fertilizer manufacturer to a diversified chemical company with a global footprint. Headquartered in Tokyo, Japan, the company operates through three primary segments: Material, Homes, and Health Care. The Material segment produces a wide array of chemical products, including caustic soda, acrylonitrile, polymers, and additives, serving industries ranging from automotive to electronics. The Homes segment focuses on construction materials and housing solutions, including autoclaved aerated concrete and home construction. The Health Care segment offers pharmaceuticals, diagnostic reagents, dialyzers, and medical devices. Asahi Kasei's integrated business model allows it to leverage synergies across its segments and adapt to changing market demands. The company's commitment to research and development has resulted in innovative products and technologies, strengthening its competitive position in the global market.
What Products and Services Does AHKSF Offer?
- Manufactures and sells chemical products, including caustic soda, acrylonitrile, and polymers.
- Provides housing solutions, including autoclaved aerated concrete and home construction.
- Offers healthcare products, including pharmaceuticals, diagnostic reagents, and medical devices.
- Produces electronic materials and lithium-ion battery separators.
- Develops and markets sustainable and environmentally friendly products.
- Provides mortgage financing, asset management services, and insurance products.
How Does AHKSF Make Money?
- Operates through three segments: Material, Homes, and Health Care.
- Generates revenue from the sale of chemical products, construction materials, and medical devices.
- Focuses on research and development to create innovative products and technologies.
- Leverages its integrated business model to create synergies across its segments.
What Industry Does AHKSF Operate In?
Asahi Kasei operates within the global chemicals industry, a sector characterized by cyclical demand and intense competition. The industry is influenced by macroeconomic factors, raw material prices, and technological advancements. Asahi Kasei's diversified business model allows it to mitigate risks associated with specific end markets. The company competes with other major chemical companies, including BNTGF (BASF) and BZZUF (Bayer), in various segments. The global chemicals market is expected to grow in the coming years, driven by increasing demand from emerging economies and advancements in materials science.
Who Are AHKSF's Key Customers?
- Automotive industry (suppliers of plastics and synthetic rubber)
- Electronics industry (suppliers of electronic materials)
- Construction industry (suppliers of construction materials)
- Healthcare providers (suppliers of pharmaceuticals and medical devices)
Research confidence
Enough evidence to be useful, with gaps worth knowing about.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 73 days ago
- ● No analyst coverage
- ● Reported in JPY, converted to USD
Why 46?
This rating comes from our nine-signal model, which produces a score but not a per-factor breakdown. The sector-relative five-pillar model, which explains its own contributions, does not cover this listing yet. How the score is built →
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 46 |
| 2026-08-26 | 46 |
| 2026-08-29 | 46 |
| 2026-09-01 | 46 |
| 2026-09-04 | 46 |
| 2026-09-07 | 46 |
| 2026-09-10 | 46 |
What changed?
The score has stayed at 46.
Over the same 18 days the stock moved +5.5%.
Earnings Track Record
Asahi Kasei Corporation has beaten Wall Street's EPS estimate in 6 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 16.1% above estimates on average.
Quarterly Financial Performance: Asahi Kasei Corporation
Revenue for Asahi Kasei Corporation came in at $5.34B during Q1 FY2027. The company recorded net income of $347.3M, with diluted EPS of $0.26. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this large-cap Basic Materials company. Across the four most recent quarters, AHKSF averaged $0.23 in diluted EPS.
AHKSF Valuation & Market Position
With a $13.9B market cap, Asahi Kasei Corporation sits in the large-cap segment of the market. Relative to its peer group, AHKSF's quantitative score of 46/100 is roughly in line with the peer average of 49/100.
Key Financial Metrics
Return on equity for Asahi Kasei Corporation stands at 8.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 3.8%, showing how much profit it generates from its asset base. AHKSF trades at a trailing price-to-earnings ratio of 10.92, below the Basic Materials sector average of ~21.40x. Its free cash flow yield is 4.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.35 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 6.6%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Asahi Kasei Corporation's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 2.19 places it in the grey zone, a middle ground that warrants monitoring.
Company Profile
Asahi Kasei Corporation operates in the Conglomerates industry within the Industrials sector. It is headquartered in Tokyo, JP. The company is led by CEO Koshiro Kudo. AHKSF has traded publicly since 2002.
AHKSF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Diversified business model
- Global presence
- Strong research and development capabilities
- Integrated business model
Bear Case
- Exposure to cyclical industries
- Dependence on raw material prices
- Competition from larger chemical companies
- Geographic concentration in Japan
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 FY2027 | $5.34B | $347M | $0.26 |
| Q4 FY2026 | $5.33B | $250M | $0.18 |
| Q3 FY2026 | $5.05B | $354M | $0.26 |
| Q2 FY2026 | $4.94B | $307M | $0.23 |
Q1 FY2027 · filed 30 Jun 2026 · Financial Modeling Prep
Based on FMP financials and quantitative analysis · Converted to USD from JPY at today's rate
AHKSF Latest News
-
Veloxis Pharmaceuticals Doses First Patient in RENGEVITY-201 Phase 2 Trial of Pegrizeprument for the Prevention of Organ Rejection in Kidney Transplant Recipients
Yahoo! Finance: AHKSF News · Aug 31, 2026
-
Amid Genomatica and Asahi Kasei Scaling Microbial Fermentation for Bio-Nylon 6,6, New Report Analyzes Global Bio-Adipic Acid Expansion
Yahoo! Finance: AHKSF News · Aug 14, 2026
-
Stocks That Hit 52-Week Highs On Tuesday
· Mar 24, 2020
-
Stocks That Broke Yearly Lows Tuesday Morning
· Aug 6, 2019
AHKSF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for AHKSF.
Price Targets
Wall Street price target analysis for AHKSF.
AHKSF MoonshotScore
What does this score mean?
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. AHKSF scores 46/100 (Grade C): the number comes from the legacy nine-factor engine (quantitative signals from revenue growth to news sentiment), written once, not refreshed.
Latest News
Veloxis Pharmaceuticals Doses First Patient in RENGEVITY-201 Phase 2 Trial of Pegrizeprument for the Prevention of Organ Rejection in Kidney Transplant Recipients
Amid Genomatica and Asahi Kasei Scaling Microbial Fermentation for Bio-Nylon 6,6, New Report Analyzes Global Bio-Adipic Acid Expansion
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Broke Yearly Lows Tuesday Morning
Leadership: Koshiro Kudo
CEO
Koshiro Kudo is the CEO of Asahi Kasei Corporation. As the CEO, he is responsible for overseeing the company's overall strategy and operations across its three segments: Material, Homes, and Health Care.
Track Record: Due to the limited information available, specific achievements, strategic decisions, and company milestones under Koshiro Kudo's leadership cannot be detailed. However, as CEO of a large, diversified company like Asahi Kasei, he likely plays a key role in driving growth, innovation, and profitability.
AHKSF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Asahi Kasei Corporation (AHKSF) may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as those listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the potential for less transparency and liquidity.
- OTC Tier: OTC Other
- Limited liquidity due to low trading volume.
- Lack of regulatory oversight and transparency.
- Potential for price manipulation and fraud.
- Higher bid-ask spreads increasing transaction costs.
- Limited financial information and reporting requirements.
- Verify the company's financial statements and disclosures.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's OTC tier and disclosure status.
- Monitor trading volume and bid-ask spreads.
- Consult with a financial advisor before investing.
- Understand the risks associated with OTC investing.
- Established history as a diversified chemical company founded in 1922.
- Global presence with operations in Japan and internationally.
- Operations across multiple sectors: Materials, Homes and Healthcare.
- Market capitalization of $13.9B suggests a substantial company.
- Presence of a dividend yield of 2.51%.
Asahi Kasei Corporation Basic Materials Stock: Key Questions Answered
What does the AI Score mean for AHKSF?
AHKSF holds an AI Score of 46/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. The number comes from the legacy nine-factor engine (quantitative signals from revenue growth to news sentiment), written once, not refreshed. Asahi Kasei Corporation is a diversified Japanese chemical company operating across materials, homes, and healthcare segments.
Is AHKSF a good stock?
Stock Expert AI does not rate AHKSF buy, sell or hold. Asahi Kasei Corporation carries a MoonshotScore of 46/100 on the legacy nine-factor engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What does Asahi Kasei Corporation do?
Asahi Kasei Corporation is a diversified Japanese company that operates in three main segments: Material, Homes, and Health Care. The Material segment produces chemicals, polymers, and electronic materials.
What are the key factors to evaluate for AHKSF?
Asahi Kasei Corporation (AHKSF) holds a MoonshotScore of 46/100 (low). P/E: 10.92x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does AHKSF data refresh on this page?
AHKSF's price was last updated on Sep 10, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven AHKSF's recent stock price performance?
Asahi Kasei Corporation (AHKSF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified business model. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider AHKSF overvalued or undervalued right now?
Asahi Kasei Corporation (AHKSF) trades at 10.92x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of AHKSF?
Yes, most major brokerages offer fractional shares of Asahi Kasei Corporation (AHKSF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track AHKSF's earnings and financial reports?
Asahi Kasei Corporation (AHKSF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for AHKSF earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.